Rep. Mitch Little criticizes Wall Street Journal and comments on Ken Paxton in April tweets

Mitch Little, Texas State Representative of the 65th district (R)
Mitch Little, Texas State Representative of the 65th district (R)
0Comments

Rep. Mitch Little, a Republican elected to the Texas State House in 2025 representing the 65th district, posted a series of tweets on April 16, 2026, commenting on media bias and ongoing political developments.

In one tweet from April 16, 2026, Little criticized a major national newspaper: “The degree to which the Wall Street Journal has been captured by the RINO establishment needs to be studied in journalism schools.”

Later that day, he referenced Texas Attorney General Ken Paxton in another post: “Well, I’d like to see Ol’ Kenny Paxton wriggle his way out of THIS jam!” *Paxton wriggles his way out of the jam easily* “Ah, well. Nevertheless,”

A third tweet from Little at nearly the same time contained only a link: https://t.co/cNcFEhnCjA

Little succeeded Kronda Thimesch as representative for Texas’s 65th House district following his election in 2025.



Related

Dallas

Dallas Mayor and city leaders to launch fifth annual Summer of Safety campaign

Dallas Mayor Eric L. Johnson joined other city leaders on May 18 to announce the launch of the fifth annual Summer of Safety campaign. The initiative aims to promote public safety throughout Dallas during summer months by bringing together various departments and community partners.

Mitch Little, Texas State Representative of the 65th district (R)

Rep. Mitch Little highlights Collin County lore and urges voter turnout in recent posts

Rep. Mitch Little posted a series of updates between May 16-17, 2026 highlighting Collin County stories and reminding Texans to vote.

Jim Traficant, Chief of Staff of FDA

FDA inspects Baylor University Medical Center Transfusion Services in Dallas on April 22

Baylor University Medical Center Transfusion Services in Dallas underwent a U.S. Food and Drug Administration inspection for blood and blood products on April 22, as listed on the FDA’s online dashboard.